Mylan Pharmaceuticals Inc recalls Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons…
Labeling: Missing label: Label missing from some prefilled pens.
Read the official notice →- Date
- 2022-08-03
- Country
- United States
- Brand
- Mylan Pharmaceuticals
- Product
- Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5…
- Classification
- Class I
- Units
- Product was distributed nationwide within the United States
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Mylan Pharmaceuticals recalls
- 2026-08-05
US- 2026-03-11
- US
- 2025-03-26
- US
MYLAN PHARMACEUTICALS INC recalls Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC…
Failed Dissolution Specifications - low dissolution results
- 2022-05-04
- US
- 2022-04-27
- US
Mylan Pharmaceuticals Inc recalls Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505…
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
- 2022-04-13
- US
Mylan Pharmaceuticals Inc recalls Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV…
Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine…
Other drugs & medical recalls in the United States
- 2022-08-03
- US
- US
Jubilant Cadista Pharmaceuticals, Inc. recalls Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661,…
Failed Dissolution Specifications
FDA · DrugJubilant Cadista Pharmaceuticals, Inc.Nationwide within the United StatesOfficial notice → - US
Jubilant Cadista Pharmaceuticals, Inc. recalls Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661,…
Failed dissolution specifications.
FDA · DrugJubilant Cadista Pharmaceuticals, Inc.Nationwide within the United StatesOfficial notice → - US
SUN PHARMACEUTICAL INDUSTRIES INC recalls Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries,…
Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.
- US
The Procter & Gamble Company recalls Crest 3D White Fluoride Anticavity Toothpaste, Advanced Triple Whitening, 0.243% sodium fluoride, Net Wt. 5.6 oz (158 g) a)…
Labeling: Missing label: the product tube was missing a label and contained a different formulation.
- US
Teva Pharmaceuticals USA Inc recalls Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx Only, 30 unit-dose packets per box. Manufactured by:…
Superpotent Drug: Out of specification assay result was obtained during stability testing.